hydralazine has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the activity and safety of hydralazine and valproate (Transkrip) in cutaneous T-cell lymphoma (CTCL)." | 9.24 | Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study. ( Candelaria, M; Cervera, E; Dueñas-González, A; Espinoza-Zamora, JR; Labardini-Méndez, J; López-González, C; Lozano-Zavaleta, V; Sosa-Espinoza, A; Toledano-Cuevas, DV; Vieyra-García, M; Zapata-Canto, N, 2017) |
| "To evaluate the activity and safety of hydralazine and valproate (Transkrip) in cutaneous T-cell lymphoma (CTCL)." | 5.24 | Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study. ( Candelaria, M; Cervera, E; Dueñas-González, A; Espinoza-Zamora, JR; Labardini-Méndez, J; López-González, C; Lozano-Zavaleta, V; Sosa-Espinoza, A; Toledano-Cuevas, DV; Vieyra-García, M; Zapata-Canto, N, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espinoza-Zamora, JR | 1 |
| Labardini-Méndez, J | 1 |
| Sosa-Espinoza, A | 1 |
| López-González, C | 1 |
| Vieyra-García, M | 1 |
| Candelaria, M | 1 |
| Lozano-Zavaleta, V | 1 |
| Toledano-Cuevas, DV | 1 |
| Zapata-Canto, N | 1 |
| Cervera, E | 1 |
| Dueñas-González, A | 1 |
1 trial available for hydralazine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease- | 2017 |